Design and Rationale of the COMMIT-LAD Registry: A Comprehensive Analysis of Medical and Invasive Treatment

Roberto Bova1, Janneke Bastings2, Matteo Betti1

  • 1Department of Cardiology, Maastricht University Medical Center, Maastricht, the Netherlands.

Insights

The COMMIT LAD registry tracks outcomes for patients with diffuse left anterior descending (LAD) coronary artery disease (CAD). It compares major adverse cardiovascular events (MACE) for surgical versus medical treatments over one year.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • Coronary artery disease (CAD) management requires differentiating focal from diffuse lesions, especially in the left anterior descending (LAD) artery.
  • Diffuse LAD disease poses treatment challenges, with options including optimal medical therapy (OMT) and coronary artery bypass grafting (CABG), contrasting with percutaneous coronary intervention (PCI) for focal lesions.

Purpose of the Study:

  • To assess the one-year incidence of major adverse cardiovascular events (MACE) in patients with symptomatic, significant LAD disease treated for diffuse lesions.
  • To evaluate patient-reported symptom burden and quality of life as secondary endpoints in diffuse LAD disease management.

Main Methods:

  • The COMMIT LAD registry is a prospective, multicenter observational study initiated in the Netherlands.
  • It enrolls patients with symptomatic and significant LAD disease, collecting longitudinal data over 12 months.
  • Outcomes are compared between patients receiving surgical (CABG) or pharmacological (OMT) treatments for diffuse LAD disease.

Main Results:

  • The study aims to provide a real-world overview of current treatment approaches for LAD disease.
  • It will highlight differences in outcomes between diffuse and focal CAD patterns.
  • Comparative outcomes between surgical and pharmacological treatments for diffuse LAD disease will be analyzed.

Conclusions:

  • The COMMIT LAD registry offers insights into clinical practice patterns and patient experiences for LAD disease.
  • Findings are expected to inform clinicians on comparative outcomes for diffuse LAD disease.
  • The study aims to guide more tailored treatment strategies for patients with diffuse CAD.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
544
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
424
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
409
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
539